Fig. 6From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer modelThe representative images of TROP-2 IHC staining of TROP-2 positive MDA-MB-231 (A) and TROP-2 negative ACHN (B) xenograft tumors, illustrating the weak to moderate specific TROP-2 over-expression of MDA-MB-231 tumor samplesBack to article page